Sonoma Pharmaceuticals, Inc. (SNOA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $174.0K2012: $336.0K2013: $257.0K2014: $504.0K2015: $139.0K2016: $345.0K2017: $394.0K2018: $187.0K2019: $100.0K2020: $206.0K2021: $179.0K2022: $137.0K2023: $269.0K2024: $2.0K2025: $80.0K2026: $192.0K$192.0K
2011Capital Expenditures (USD)2026
Fiscal YearCapital ExpendituresChange YoY
2026$192.0K+140.0%
2025$80.0K+3900.0%
2024$2.0K-99.3%
2023$269.0K+96.4%
2022$137.0K-23.5%
2021$179.0K-13.1%
2020$206.0K+106.0%
2019$100.0K-46.5%
2018$187.0K-52.5%
2017$394.0K+14.2%
2016$345.0K+148.2%
2015$139.0K-72.4%
2014$504.0K+96.1%
2013$257.0K-23.5%
2012$336.0K+93.1%
2011$174.0K